Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2005
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277585 Combinations of immunosupressive agents for the treatment or prevention of graft rejections
12/15/2005US20050277583 Histone deacetylase inhibitors and process for producing the same
12/15/2005US20050277112 Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050276820 structural modification alters the biological persistence, preferably the biological half-life
12/15/2005US20050276789 Immunostimulatory oligonucleotides and uses thereof
12/15/2005US20050274671 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/15/2005DE10128980B4 Gen-modifizierte alloreaktive T-Zellen, Verfahren zu ihrer Herstellung und ihre Verwendung Gene-modified alloreactive T-cells, processes for their preparation and their use
12/15/2005CA2709865A1 Method for improved breast milk feeding to reduce the risk of allergy
12/15/2005CA2580305A1 Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
12/15/2005CA2569098A1 Combination therapy with glatiramer acetate and minocycline for the treatment of multiple sclerosis
12/15/2005CA2564529A1 Preventing autoimmune disease
12/15/2005CA2561861A1 Antibodies to angiogenesis inhibiting domains of cd148
12/15/2005CA2560472A1 Method for improved breast milk feeding to reduce the risk of allergy
12/14/2005EP1605052A2 A method for producing influenza hemagglutinin multivalent vaccines
12/14/2005EP1605039A1 Dendritic cell presenting alpha-glycosylceramide derivative and a ntigen and usable in suppressing immune response
12/14/2005EP1604984A1 Water-soluble phenylpyridazine derivative and medicine containing the same
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604981A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1604684A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
12/14/2005EP1604665A1 C-kit kinase inhibitor
12/14/2005EP1604650A2 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
12/14/2005EP1603949A2 Antibodies against human il-21 receptor and uses therefor
12/14/2005EP1603917A1 Immunomodulating heterocyclic compounds
12/14/2005EP1603898A2 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent
12/14/2005EP1603591A2 Allergen peptide fragments and use thereof
12/14/2005EP1603559A1 Pharmaceutical composition for intracellular acidification with cis-urocanic
12/14/2005EP1603555A2 Halogenated triptolide derivatives as immunomodulators and anticancer agents
12/14/2005EP1603409A2 Salutary compositions consisting of fungi containing lipids and thiocyanates
12/14/2005EP1492550B1 Willow extract
12/14/2005EP1326858B1 Piperidine compounds as anti-allergic
12/14/2005EP1263968B1 Beta 1, 2-xylosyltransferase-gene from arabidopsis
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005EP1178821B1 Use of anti-hbp antibodies in the inhibition of bradykinin release
12/14/2005EP1177292B1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
12/14/2005EP1165125B1 Antigen-specific induction of peripheral immune tolerance
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005EP1091975B1 Novel cyclosporin with improved activity profile
12/14/2005EP1080198B1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/14/2005EP1007047B1 Use of mizolastine for preparing a medicine for treating inflammation
12/14/2005EP0858504B1 Diagnostics and treatments of periodontal disease
12/14/2005CN1708500A Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide and use as inhibitor of the interaction of CAMs and leukointegrins
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1708300A Peroral preparation for prevention of or treatment for atopic dermatitis
12/14/2005CN1706955A Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF
12/14/2005CN1706838A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/14/2005CN1706833A Formyl peptide-like acceptor-1 regulator and its prepn and use
12/14/2005CN1231585C Method for preparing recombinant duck interleukin-2 protein and its application
12/14/2005CN1231474C Salts of aiso thiazole-4-carboxamide and their use as anti-hyperproliferatin agents
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof
12/14/2005CN1231459C Novel aminobenzophenones
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/14/2005CN1231208C Pharmaceutical compositions
12/13/2005US6974872 Process for production of piperidine derivatives
12/13/2005US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974817 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
12/13/2005US6974809 Inhibitors of interleukin 1-β converting enzyme
12/13/2005US6974596 Comprising cedrol, cedrenol, farnesol, patchouli alcohol or vetiverol; antiallergic agents and atopic dermatitis preventives
12/13/2005US6974594 Method of preparing biological materials and preparations produced using same
12/13/2005US6974576 Extracts provided by the present invention have a higher immune stimulatory activity than extracts prepared and used in the art
12/13/2005US6974572 Peptide for use in the treatment of allergic disorders
12/13/2005CA2271054C Substituted phenols and thiophenols useful as antioxidant agents
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/13/2005CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds
12/13/2005CA2090634C Novel cyclosporins
12/08/2005WO2005116188A1 Lactic acid bacteria with immunoregulating activities
12/08/2005WO2005116187A1 Industrial fermenting production process of hirsutezla hepiali chen & shen of anamorphic fungi related to chinese cordyceps sinensis
12/08/2005WO2005116067A2 Msh-agonist tripeptide conjugates
12/08/2005WO2005116066A1 Peptides derived from decorin leucine rich repeats and uses thereof
12/08/2005WO2005115468A1 Novel drug discovery target and medicine acting on the same
12/08/2005WO2005115376A1 Pharmaceutical products for treating neoplastic disease and inflammation
12/08/2005WO2005115369A2 Use of ppar agonists to treat ruminants
12/08/2005WO2005074968A3 Medical use of basic peptides
12/08/2005WO2004099126A8 N-(2-PHENYLETHYL)SULFAMIDE DERIVATIVES AS INTEGRIN α4 ANTAGONISTS
12/08/2005WO2004069173A3 Methods for modulating an inflammatory response
12/08/2005WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272806 Injectable formulations of taxanes for cad treatment
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272780 Small molecule inhibitors of rotamase enzyme activity
12/08/2005US20050272771 Such as terfenadine carboxylic acid metabolite and carebastine using a 4-(4-halo-1-oxobutyl)-alpha,alpha-dimethyl-alpha-substituted toluene intermediate
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272739 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/08/2005US20050272733 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272701 Pharmaceutical composition
12/08/2005US20050272694 Composition containing beta-glucan and constipation-relieving drug, immunopotentiatior, and skin moistening agent using the composition
12/08/2005US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use
12/08/2005US20050272151 Dendritic cell line
12/08/2005US20050272132 For therapy of a fungal infection
1 ... 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 ... 1172